The Council for Responsible Nutrition strongly criticized the Center for Science in the Public Interest earlier this week as that organization petitioned the Food and Drug Administration to prohibit the sale of Ginkgo biloba.
Following a report published Monday in The New York Times about how high doses of the supplement ginkgo biloba caused cancer in lab animals, many are calling for the removal of the product from store shelves to prevent consumer consumption.
A court in France has ordered generic drug maker Mylan to pay French drug maker Ipsen $24 million for allegedly misleading marketing of a drug, according to published reports.
